IView Therapeutics was awarded SBIR Innovative grant by NIH’s National Institute of Allergy and Infectious Diseases (NIAID)

By WebmasterMarch 23, 2018November 1st, 2024No Comments

IView Therapeutics was awarded SBIR Innovative grant by NIH’s National Institute of Allergy and Infectious Diseases (NIAID)

Previous PostDr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
Next PostData on Cancer Resistance Pathway Inhibitor IT-139 to be Presented at AACR 2018 Annual Meeting